PAK

Signaling Pathway

PAK Signaling Pathway

PAK Products

  • All (11)
  • PAK Inhibitors (11)
  • New PAK Products
Catalog No. Product Name Information Product Use Citations Product Validations
S8032 PRT062607 (P505-15) HCl PRT062607 (P505-15, BIIB057, PRT-2607) HCl is a novel, highly selective Syk inhibitor with IC50 of 1 nM in cell-free assays, >80-fold selective for Syk than Fgr, PAK5, Lyn, FAK, Pyk2, FLT3, MLK1 and Zap70.
J Exp Med, 2023, 220(9)e20230054
Adv Sci (Weinh), 2023, 10(10):e2205397
J Thromb Haemost, 2023, 21(8):2236-2247
S7093 IPA-3 IPA-3 is a selective non-ATP competitive Pak1 inhibitor with IC50 of 2.5 μM in a cell-free assay, no inhibition to group II PAKs (PAKs 4-6).
Cell Death Dis, 2023, 14(7):463
Cell Death Dis, 2023, 14(7):463
iScience, 2023, 26(8):107333
S7271 FRAX597 FRAX597 is a potent, ATP-competitive inhibitor of group I PAKs with IC50 of 8 nM, 13 nM, and 19 nM for PAK1, PAK2, and PAK3, respectively.
Sci Rep, 2024, 14(1):4060
Nat Commun, 2023, 14(1):700
J Exp Clin Cancer Res, 2023, 42(1):56
S7094 PF-3758309 PF-03758309 (PF-03758309) is a potent, ATP-competitive, pyrrolopyrazole inhibitor of PAK4 with Kd of 2.7 nM. PF-3758309 is antiproliferative and induces apoptosis in a HCT116 tumor model.
Oncogene, 2023, 42(39):2878-2891
Oncogene, 2023, 10.1038/s41388-023-02809-0
Biomolecules, 2023, 13(1)100
S7807 FRAX486 FRAX486 is a potent p21-activated kinase (PAK) inhibitor with IC50 values of 14, 33, 39 and 575 nM for PAK1, PAK2, PAK3 and PAK4 respectively.
iScience, 2023, 26(8):107333
Biochim Biophys Acta Mol Cell Res, 2022, 1869(8):119264
Mol Cell, 2020, 80(6):1104-1122.e9
S8444 KPT 9274 (ATG-019) KPT 9274 ( ATG-019) is an orally bioavailable small molecule that is a non-competitive dual inhibitor of PAK4 and NAMPT. It shows an IC50 of ~120 nM for NAMPT in a cell-free enzymatic assay.
Cell Rep Med, 2024, 5(2):101416
Sci Rep, 2023, 13(1):3334
Sci Adv, 2023, 9(15):eadf8522
S7989 FRAX1036 FRAX-1036 is a potent and selective PAK inhibitor with biochemical potency (Ki) of 23.3 nM and 72.4 nM against PAK1 and PAK2.
bioRxiv, 2023, 10.1101/2023.12.15.571909
Cell Rep, 2022, 41(1):111442
Nature, 2021, 595(7869):730-734
S8264 NVS-PAK1-1 NVS-PAK1-1 is a potent and selective allosteric p21-activated kinase 1 (PAK1) inhibitor with an IC50 of 5 nM.
NPJ Breast Cancer, 2023, 9(1):48
S1976 LCH-7749944 LCH-7749944 (GNF-PF-2356) is a novel and potent p21-activated kinase 4 (PAK4) inhibitor with an IC50 of 14.93 μM and has less potently inhibitory effect against PAK1, PAK5 and PAK6. LCH-7749944 causes successful inhibition of EGFR activity due to its inhibitory effect on PAK4.
Endocrinology, 2023, 164(6)bqad073
E2484 Hydrastine Hydrastine ((-)-β-Hydrastine; (1R,9S)-β-Hydrastine), a natural alkaloid present in Hydrastis canadensis, is an inhibitor of PAK4.
E2380 GNE 2861 GNE 2861, a PAK inhibitor that displays group II selectivity, inhibits PAK4, PAK5 and PAK6 with IC50s of 7.5, 36, 126 nM, respectively.
S8032 PRT062607 (P505-15) HCl PRT062607 (P505-15, BIIB057, PRT-2607) HCl is a novel, highly selective Syk inhibitor with IC50 of 1 nM in cell-free assays, >80-fold selective for Syk than Fgr, PAK5, Lyn, FAK, Pyk2, FLT3, MLK1 and Zap70.
J Exp Med, 2023, 220(9)e20230054
Adv Sci (Weinh), 2023, 10(10):e2205397
J Thromb Haemost, 2023, 21(8):2236-2247
S7093 IPA-3 IPA-3 is a selective non-ATP competitive Pak1 inhibitor with IC50 of 2.5 μM in a cell-free assay, no inhibition to group II PAKs (PAKs 4-6).
Cell Death Dis, 2023, 14(7):463
Cell Death Dis, 2023, 14(7):463
iScience, 2023, 26(8):107333
S7271 FRAX597 FRAX597 is a potent, ATP-competitive inhibitor of group I PAKs with IC50 of 8 nM, 13 nM, and 19 nM for PAK1, PAK2, and PAK3, respectively.
Sci Rep, 2024, 14(1):4060
Nat Commun, 2023, 14(1):700
J Exp Clin Cancer Res, 2023, 42(1):56
S7094 PF-3758309 PF-03758309 (PF-03758309) is a potent, ATP-competitive, pyrrolopyrazole inhibitor of PAK4 with Kd of 2.7 nM. PF-3758309 is antiproliferative and induces apoptosis in a HCT116 tumor model.
Oncogene, 2023, 42(39):2878-2891
Oncogene, 2023, 10.1038/s41388-023-02809-0
Biomolecules, 2023, 13(1)100
S7807 FRAX486 FRAX486 is a potent p21-activated kinase (PAK) inhibitor with IC50 values of 14, 33, 39 and 575 nM for PAK1, PAK2, PAK3 and PAK4 respectively.
iScience, 2023, 26(8):107333
Biochim Biophys Acta Mol Cell Res, 2022, 1869(8):119264
Mol Cell, 2020, 80(6):1104-1122.e9
S8444 KPT 9274 (ATG-019) KPT 9274 ( ATG-019) is an orally bioavailable small molecule that is a non-competitive dual inhibitor of PAK4 and NAMPT. It shows an IC50 of ~120 nM for NAMPT in a cell-free enzymatic assay.
Cell Rep Med, 2024, 5(2):101416
Sci Rep, 2023, 13(1):3334
Sci Adv, 2023, 9(15):eadf8522
S7989 FRAX1036 FRAX-1036 is a potent and selective PAK inhibitor with biochemical potency (Ki) of 23.3 nM and 72.4 nM against PAK1 and PAK2.
bioRxiv, 2023, 10.1101/2023.12.15.571909
Cell Rep, 2022, 41(1):111442
Nature, 2021, 595(7869):730-734
S8264 NVS-PAK1-1 NVS-PAK1-1 is a potent and selective allosteric p21-activated kinase 1 (PAK1) inhibitor with an IC50 of 5 nM.
NPJ Breast Cancer, 2023, 9(1):48
S1976 LCH-7749944 LCH-7749944 (GNF-PF-2356) is a novel and potent p21-activated kinase 4 (PAK4) inhibitor with an IC50 of 14.93 μM and has less potently inhibitory effect against PAK1, PAK5 and PAK6. LCH-7749944 causes successful inhibition of EGFR activity due to its inhibitory effect on PAK4.
Endocrinology, 2023, 164(6)bqad073
E2484 Hydrastine Hydrastine ((-)-β-Hydrastine; (1R,9S)-β-Hydrastine), a natural alkaloid present in Hydrastis canadensis, is an inhibitor of PAK4.
E2380 GNE 2861 GNE 2861, a PAK inhibitor that displays group II selectivity, inhibits PAK4, PAK5 and PAK6 with IC50s of 7.5, 36, 126 nM, respectively.

Choose Selective PAK Inhibitors

Tags: PAK inhibitor|PAK agonist|PAK activator|PAK inducer|PAK antagonist|PAK signaling pathway|PAK assay kit